Looking for insights on leadership? Listen to Brian J. Bolwell, MD, FACP, Chairman of the Taussig Cancer Institute and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine, discuss his own leadership journey and lessons learned.

Naveen Pemmaraju, MD, discusses the therapeutic landscape of ultra-rare cancers as well as the importance of ongoing research in these patient populations. Additionally, he shares his own passion for this area of study and how it has shaped his career.

Muzaffar H. Qazilbash, MD, from The University of Texas MD Anderson Cancer Center, Houston, discusses what he loves about hematology/oncology, including patient interactions and lifelong learning.

Find out what intrigued HemOnc Times Editorial Advisory Board Member Pamela Crilley, DO, Cancer Treatment Center of America, Philadelphia, about working in hematology/oncology and why she is passionate about the profession.

HemOnc Times Editorial Advisory Board Member Margaret ‘Margie’ Kasner, MD, MSCE, of Sidney Kimmel Cancer Center – Jefferson Health, Philadelphia, shares her passion for the field of hematology/oncology as well as one of her most memorable patient experiences.

Andrew Zelentz, MD, PhD, Chief of the Lymphoma Service and Vice Chair of Medical Informatics at Memorial Sloan Kettering Cancer Center, tells OT how oncologists there are training a computer to understand and compare big data sets…

Here’s why he says that work will help cancer patients at MSKCC and beyond.

David E. Weissman, MD, founded the Palliative Care Center at the Medical College of Wisconsin, serves as Director of the Medical School Palliative Care Education Project, and is also Co-Director of the Center to Advance Palliative Care’s initiative to help oncs meet revised standards of care (Improving Palliative Care—Outpatients [OPAL-OP]).

Listen to what he told OT are the trends in palliative care he sees in practice

Alen Voskanian, MD—Innovation Advisor to the Centers for Medicare and Medicaid Services—describes the CMS project to test new payment and service delivery models.

He shared with OT the key clinical implications for oncologists and the whole cancer care team.